Clinical trial / 2022
Supplementation with açaí extract for three months significantly reduced tinnitus discomfort in a randomized, placebo-controlled trial.
A randomized, placebo-controlled trial evaluated the effects of 100 mg of açaí extract for three months versus placebo in 30 individuals with chronic tinnitus. The açaí group experienced a reduction in tinnitus discomfort assessed via the Tinnitus Handicap Inventory (p = 0.006). Significant differences in common anxiety disorder symptoms were observed in the placebo group (p = 0.016), but no significant differences were observed for oxidative metabolism biomarkers, although values decreased post-treatment in all groups.
- Study type
- Randomized, placebo-controlled clinical trial
- Who was studied
- 30 individuals (average age 50.5 years, 14 males and 16 females) with chronic tinnitus and normal hearing or mild sensorineural hearing loss
- What was measured
- Tinnitus Handicap Inventory (THI), Beck's Anxiety Inventory (BAI), and oxidative stress biomarkers (lipid peroxidation and protein carbonylation)
THE PAPER
Supplementation with açaí (Euterpe Oleracea Martius) for the treatment of chronic tinnitus: effects on perception, anxiety levels and oxidative metabolism biomarkers.
Oppitz SJ, Garcia MV, Bruno RS, Zemolin CM, Baptista BO, Turra BO, Barbisan F, Cruz IBMD, Silveira AFD. Codas, 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.